Mario Ermani

4.7k citations
58 papers · 3.6k indexed · 1 hit paper · h-index 31

Impact in

Papers in

Mario Ermani

57 papers receiving 3.5k citations

Hit Papers

MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients 2008 · 634 citations
6342008202620142020200400600

Peers

Mario Ermani
Comparison fields: 5 of 107
  • Genetics 2.6k
  • Cancer Research 688
  • Pulmonary and Respiratory Medicine 1.3k
  • Internal Medicine 118
  • Neurology 403
Replace Kathryn E. Dusenbery with:
Kathryn E. Dusenbery United States
Karin Dieckmann Austria
D. Couanet France
David Macdonald Canada
Nina A. Paleologos United States
C Kalifa France
Daniel C. Bowers United States
Farshad Nassiri Canada
Karen J. Marcus United States
Bettina Hentschel Germany
Mario Ermani relative to Kathryn E. Dusenbery United States Kathryn E. Dusenbery's profile →
Citations per field
00.5×4.8×
Kathryn E. Dusenbery · 1×
Citations per year

Countries citing papers authored by Mario Ermani

Since Specialization
Citations

This map shows the geographic impact of Mario Ermani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Ermani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Ermani more than expected).

Fields of papers citing papers by Mario Ermani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Ermani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Ermani. The network helps show where Mario Ermani may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mario Ermani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mario Ermani Line = papers co-authored together Mario Ermani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201625
2 201620
3 20135
4 201033
5 201099
6 200973
7 2009181
8 200862
9 2007100
10 200617
11 20068
12 2006185
13 200555
14 200434
15 200357
16 200324
17 2003132
18 200251
19 199841
20 1997164

About Mario Ermani

Mario Ermani is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Hepatology, having authored 58 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (38 papers), Brain Metastases and Treatment (21 papers), Meningioma and schwannoma management (8 papers), Cancer Treatment and Pharmacology (8 papers), Histone Deacetylase Inhibitors Research (7 papers), Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Genetics (2.6k citations), Cancer Research (688 citations), Pulmonary and Respiratory Medicine (1.3k citations), Internal Medicine (118 citations) and Neurology (403 citations). Mario Ermani has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Alba A. Brandes, Enrico Franceschi, Alicia Tosoni, V. Blatt, Roberta Bertorelle, F. Spagnolli, G. Frezza, Pietro Amistà, Fabio Calbucci and Annalisa Pession. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Neurology, Journal of Neuro-Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026